UQUIFA ITALIA SPA

Overview

UQUIFA ITALIA SPA is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering CARISOPRODOL USP; PYRANTEL PAMOATE USP; PYRANTEL TARTRATE ZEOLEX.

API / Drug Master Files

UQUIFA ITALIA SPA holds 3 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• PYRANTEL TARTRATE ZEOLEXActive2007-01-04
• PYRANTEL PAMOATE USPActive2006-09-29
• CARISOPRODOL USPActive2004-06-03
• DOXYLAMINE SUCCINATE USPInactive2004-05-21

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to UQUIFA ITALIA SPA in our records. PharmaTek screens the full directory against live FDA enforcement data.